NEWS
Telix Pharmaceuticals axes $25 million share purchase plan
MELBOURNE: Billion-dollar cancer imaging biotech Telix Pharmaceuticals has cancelled the $25 million share ... read more
Virtus Health shares jump to five-year high as CapVest raises bid
LONDON: UK-based CapVest Partners has lifted its non-binding offer for Virtus Health just ... read more